The 1 Stock I’d Buy With $2,500 in November and Not Check Until 2051
One retailer has been turning other companies' leftovers into a growing empire since 1976. Here's why $2,500 in it today is worth forgetting about until 2051.
·
The Motley Fool
Green Thumb Ended Its String of Profitable Quarters. Is the Stock a Buy?
Green Thumb Industries ended its run of four consecutive profitable quarters.
·
The Motley Fool
Why Nvidia Stock Looks Like a Bargain Right Now
Nvidia's shares have stalled, while its business hasn't. Here's the case for buying the dip.
·
The Motley Fool
If I Could Give My Younger Self 1 Piece of Investing Advice, This Is What It Would Be
There's no substitute for experience, but it still helps to know some important rules of thumb.
·
The Motley Fool
Revolution Medicines’ Pancreatic Cancer Drug Nearly Doubled Survival. Is the High-Flying Stock Still a Buy?
Revolution Medicines isn't profitable, but it has a drug with blockbuster potential.
·
The Motley Fool
Forget the 2026 Midterm Election Results. Warren Buffett’s Advice Makes This ETF a No-Brainer Buy
Elections come and go, but the right investing strategy can help you build lasting wealth.
·
The Motley Fool
This Dividend King Has Raised Its Payout Through Every Recession Since the 1950s. I’m Buying Before the End of the Year.
Procter & Gamble's dividend increase is one of the longest among U.S. companies and hasn't been interrupted by 10 recessions.
·
The Motley Fool
